Continuation funds reshape exit timing, affecting both private‑equity returns and the pipeline of IPOs that feed public markets, making alignment of GP‑LP interests critical.
Private‑equity exits have grown increasingly difficult as market volatility and tighter capital conditions limit traditional sale routes. To preserve value, sponsors have turned to continuation funds, a tool that repackages existing assets into a fresh vehicle and invites secondary investors to provide liquidity. This approach, once niche, now accounts for a sizable share of late‑stage PE transactions, allowing managers to defer exits until conditions improve and to retain high‑conviction holdings that could generate outsized returns.
The rise of continuation funds reverberates beyond the private‑equity sphere. By postponing IPOs and strategic sales, these vehicles shrink the pipeline of new listings, contributing to the long‑term decline in public‑equity entrants. For GPs, the structure safeguards flagship assets that bolster track records and support the next fundraising cycle, while also extending management fee streams. Yet the dual role of GP as seller and buyer raises governance concerns, as valuation decisions lack independent market pricing and may favor assets with the highest upside potential.
Investors must weigh distinct risks when considering a roll‑over. Valuation opacity can mask true asset worth, and many continuation funds concentrate on one or two companies, amplifying exposure. The extended lock‑up period—often another three to five years—means capital remains illiquid without guaranteed exit timing, while fee structures may reset, effectively charging investors twice for the same asset. Thorough due‑diligence on GP incentives, fee terms, and exit strategies is essential to ensure alignment and protect returns in this evolving landscape.
Comments
Want to join the conversation?
Loading comments...